These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 30171027)

  • 1. Clinical and molecular characteristics of
    Ohki K; Kiyokawa N; Saito Y; Hirabayashi S; Nakabayashi K; Ichikawa H; Momozawa Y; Okamura K; Yoshimi A; Ogata-Kawata H; Sakamoto H; Kato M; Fukushima K; Hasegawa D; Fukushima H; Imai M; Kajiwara R; Koike T; Komori I; Matsui A; Mori M; Moriwaki K; Noguchi Y; Park MJ; Ueda T; Yamamoto S; Matsuda K; Yoshida T; Matsumoto K; Hata K; Kubo M; Matsubara Y; Takahashi H; Fukushima T; Hayashi Y; Koh K; Manabe A; Ohara A;
    Haematologica; 2019 Jan; 104(1):128-137. PubMed ID: 30171027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype.
    Hirabayashi S; Ohki K; Nakabayashi K; Ichikawa H; Momozawa Y; Okamura K; Yaguchi A; Terada K; Saito Y; Yoshimi A; Ogata-Kawata H; Sakamoto H; Kato M; Fujimura J; Hino M; Kinoshita A; Kakuda H; Kurosawa H; Kato K; Kajiwara R; Moriwaki K; Morimoto T; Nakamura K; Noguchi Y; Osumi T; Sakashita K; Takita J; Yuza Y; Matsuda K; Yoshida T; Matsumoto K; Hata K; Kubo M; Matsubara Y; Fukushima T; Koh K; Manabe A; Ohara A; Kiyokawa N;
    Haematologica; 2017 Jan; 102(1):118-129. PubMed ID: 27634205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEF2D-BCL9 Fusion Gene Is Associated With High-Risk Acute B-Cell Precursor Lymphoblastic Leukemia in Adolescents.
    Suzuki K; Okuno Y; Kawashima N; Muramatsu H; Okuno T; Wang X; Kataoka S; Sekiya Y; Hamada M; Murakami N; Kojima D; Narita K; Narita A; Sakaguchi H; Sakaguchi K; Yoshida N; Nishio N; Hama A; Takahashi Y; Kudo K; Kato K; Kojima S
    J Clin Oncol; 2016 Oct; 34(28):3451-9. PubMed ID: 27507882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of MEF2D fusion in human B-cell precursor acute lymphoblastic leukemia cell lines.
    Akahane K; Yasuda T; Tsuzuki S; Hayakawa F; Kiyokawa N; Somazu S; Watanabe A; Kagami K; Abe M; Harama D; Goi K; Kawazu M; Kojima S; Imamura T; Goto H; Iwamoto S; Minegishi M; Abe M; Hojo H; Inaba T; Mano H; Sugita K; Inukai T
    Hematol Oncol; 2020 Oct; 38(4):614-617. PubMed ID: 32515032
    [No Abstract]   [Full Text] [Related]  

  • 5. The Molecular and Biological Function of MEF2D in Leukemia.
    Zhang P; Lu R
    Adv Exp Med Biol; 2024; 1459():379-403. PubMed ID: 39017853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MEF2D-BCL9 B-Lymphoblastic Leukemia Blast Morphology Does Not Always Mimic Mature B-Cell Leukemia.
    Baek HJ; Choi YJ; Kim BR; Lee JH; Shin MG; Kook H
    J Pediatr Hematol Oncol; 2021 Apr; 43(3):112-113. PubMed ID: 33235148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of immunophenotypic characteristics on genetic subgrouping in childhood acute lymphoblastic leukemia: Tokyo Children's Cancer Study Group (TCCSG) study L04-16.
    Ohki K; Takahashi H; Fukushima T; Nanmoku T; Kusano S; Mori M; Nakazawa Y; Yuza Y; Migita M; Okuno H; Morimoto A; Yoshino H; Kato M; Hayashi Y; Manabe A; Ohara A; Hasegawa D; Inukai T; Tomizawa D; Koh K; Kiyokawa N;
    Genes Chromosomes Cancer; 2020 Oct; 59(10):551-561. PubMed ID: 32368831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical characteristics and outcomes of childhood B-ALL with ZNF384 and MEF2D rearrangements].
    Hirabayashi S; Manabe A; Ohki K; Kiyokawa N
    Rinsho Ketsueki; 2023; 64(7):633-638. PubMed ID: 37544723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia.
    Gu Z; Churchman M; Roberts K; Li Y; Liu Y; Harvey RC; McCastlain K; Reshmi SC; Payne-Turner D; Iacobucci I; Shao Y; Chen IM; Valentine M; Pei D; Mungall KL; Mungall AJ; Ma Y; Moore R; Marra M; Stonerock E; Gastier-Foster JM; Devidas M; Dai Y; Wood B; Borowitz M; Larsen EE; Maloney K; Mattano LA; Angiolillo A; Salzer WL; Burke MJ; Gianni F; Spinelli O; Radich JP; Minden MD; Moorman AV; Patel B; Fielding AK; Rowe JM; Luger SM; Bhatia R; Aldoss I; Forman SJ; Kohlschmidt J; Mrózek K; Marcucci G; Bloomfield CD; Stock W; Kornblau S; Kantarjian HM; Konopleva M; Paietta E; Willman CL; Loh ML; Hunger SP; Mullighan CG
    Nat Commun; 2016 Nov; 7():13331. PubMed ID: 27824051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel MEF2C::SS18L1 fusion in childhood acute B-lymphoblastic leukemia.
    Chen C; Wang J; Kang M; Wu P; Zhu L; Fang Y; Xue Y
    J Cancer Res Clin Oncol; 2024 Jun; 150(6):314. PubMed ID: 38907739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel fusion gene in a pre-B acute lymphoblastic leukemia with t(1;19)(q23;p13).
    Yuki Y; Imoto I; Imaizumi M; Hibi S; Kaneko Y; Amagasa T; Inazawa J
    Cancer Sci; 2004 Jun; 95(6):503-7. PubMed ID: 15182431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a novel
    Van Outersterp I; Hormann FM; Hoogkamer AQ; Boeree A; Van den Broek SA; Den Boer ML; Boer JM
    Haematologica; 2023 Oct; 108(10):2859-2864. PubMed ID: 37051743
    [No Abstract]   [Full Text] [Related]  

  • 13. Functional, structural, and molecular characterizations of the leukemogenic driver MEF2D-HNRNPUL1 fusion.
    Zhang M; Zhang H; Li Z; Bai L; Wang Q; Li J; Jiang M; Xue Q; Cheng N; Zhang W; Mao D; Chen Z; Huang J; Meng G; Chen Z; Chen SJ
    Blood; 2022 Sep; 140(12):1390-1407. PubMed ID: 35544603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathogenic role of MEF2D-SS18 fusion gene in B-cell acute lymphoblastic leukemia.
    Zhang M; Mao D; Zhang W
    Biochem Biophys Res Commun; 2018 Feb; 496(4):1331-1336. PubMed ID: 29408457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal translocation-mediated evasion from miRNA induces strong MEF2D fusion protein expression, causing inhibition of PAX5 transcriptional activity.
    Hirano D; Hayakawa F; Yasuda T; Tange N; Yamamoto H; Kojima Y; Morishita T; Imoto N; Tsuzuki S; Mano H; Naoe T; Kiyoi H
    Oncogene; 2019 Mar; 38(13):2263-2274. PubMed ID: 30478446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and clinical characteristics of acute B-cell lymphoblastic leukemia with MEF2D fusions and report of two novel MEF2D rearrangements.
    Cao HY; Li HY; Cai WZ; Huang YH; Qiu QC; Li Z; Xu Y; Xue SL; Dai HP
    Ann Hematol; 2024 Oct; 103(10):4155-4161. PubMed ID: 38990294
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Sadras T; Müschen M
    Blood Cancer Discov; 2020 Jul; 1(1):18-20. PubMed ID: 34661138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort.
    Zaliova M; Stuchly J; Winkowska L; Musilova A; Fiser K; Slamova M; Starkova J; Vaskova M; Hrusak O; Sramkova L; Stary J; Zuna J; Trka J
    Haematologica; 2019 Jul; 104(7):1396-1406. PubMed ID: 30630978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAX5-AUTS2: a recurrent fusion gene in childhood B-cell precursor acute lymphoblastic leukemia.
    Denk D; Nebral K; Bradtke J; Pass G; Möricke A; Attarbaschi A; Strehl S
    Leuk Res; 2012 Aug; 36(8):e178-81. PubMed ID: 22578776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study.
    den Boer ML; Cario G; Moorman AV; Boer JM; de Groot-Kruseman HA; Fiocco M; Escherich G; Imamura T; Yeoh A; Sutton R; Dalla-Pozza L; Kiyokawa N; Schrappe M; Roberts KG; Mullighan CG; Hunger SP; Vora A; Attarbaschi A; Zaliova M; Elitzur S; Cazzaniga G; Biondi A; Loh ML; Pieters R;
    Lancet Haematol; 2021 Jan; 8(1):e55-e66. PubMed ID: 33357483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.